UNSPSC 51413910: Piraxelate

This classification denotes a vasodilating agent with the molecular formula C15H25NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y1P25NQI7X, chemically known as 3,3,5-trimethylcyclohexyl-2-oxo-1-pyrrolidineacetate. but generally known as piraxelate, which bears US NIH Compound Identifier 3047851. European Medicines Agency schedules Piraxelate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09895MIG.

UNSPSC 51413910 Piraxelate is a Commodity code that encompasses pharmaceutical substances used in emergency medical response, specifically advanced life support medications supplied to municipal fire and rescue services. State and local governments procuring under this code are sourcing injectable medications such as epinephrine, labetalol, adenosine, and diltiazem for use by paramedics and emergency medical technicians in pre-hospital care settings. The issuing bodies are primarily municipal purchasing departments acting on behalf of fire rescue or emergency medical services divisions. Vendors must meet strict pharmaceutical handling requirements, including expiration-date warranties of nine months or more from acceptance, defect warranties of 365 days, and expedited delivery timelines of ten calendar days or less. Bidders are required to supply Safety Data Sheets compliant with OSHA Hazard Communication Standards and accessibility documentation including Voluntary Product Accessibility Templates and WCAG 2.2 Level AA conformance attestations.

The City of Tampa's Purchasing Department posted IFB 26P00188 for Advanced Life Support Medications on April 24, 2026, with a sealed-bid response deadline of April 8, 2026 (representing a posted-after-deadline notice, indicating the solicitation closed before publication). This procurement called for 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with an estimated contract value of $40,000.00 and a one-year initial term plus two optional one-year renewals and three discretionary 30-day extensions. The solicitation included a Small Local Business Enterprise sheltered-market set-aside with a 5 percent bid discount capped at $10,000. This represents the only recent documented state or local opportunity under the code; activity appears limited to episodic municipal emergency-services procurement in Florida.